Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Metabolism of primary high-grade serous ovarian carcinoma (HGSOC) cells under limited glutamine or glucose availability

D. Šimčíková, D. Gardáš, T. Pelikán, L. Moráň, M. Hruda, K. Hložková, T. Pivetta, M. Hendrych, J. Starková, L. Rob, P. Vaňhara, P. Heneberg

. 2024 ; 12 (1) : 27. [pub] 20240916

Status not-indexed Language English Country England, Great Britain

Document type Journal Article

Grant support
324421 Univerzita Karlova v Praze
324421 Univerzita Karlova v Praze
324421 Univerzita Karlova v Praze
NU21-03-00539 Agentura Pro Zdravotnický Výzkum České Republiky

BACKGROUND: High-grade serous ovarian carcinoma (HGSOC) is the most common and aggressive subtype of epithelial ovarian carcinoma. It is primarily diagnosed at stage III or IV when the 5-year survival rate ranges between 20% and 40%. Here, we aimed to validate the hypothesis, based on HGSOC cell lines, that proposed the existence of two distinct groups of HGSOC cells with high and low oxidative phosphorylation (OXPHOS) metabolism, respectively, which are associated with their responses to glucose and glutamine withdrawal. METHODS: We isolated and cultivated primary cancer cell cultures from HGSOC and nontransformed ovarian fibroblasts from the surrounding ovarium of 45 HGSOC patients. We tested the metabolic flexibility of the primary cells, particularly in response to glucose and glutamine depletion, analyzed and modulated endoplasmic reticulum stress, and searched for indices of the existence of previously reported groups of HGSOC cells with high and low OXPHOS metabolism. RESULTS: The primary HGSOC cells did not form two groups with high and low OXPHOS that responded differently to glucose and glutamine availabilities in the cell culture medium. Instead, they exhibited a continuum of OXPHOS phenotypes. In most tumor cell isolates, the responses to glucose or glutamine withdrawal were mild and surprisingly correlated with those of nontransformed ovarian fibroblasts from the same patients. The growth of tumor-derived cells in the absence of glucose was positively correlated with the lipid trafficking regulator FABP4 and was negatively correlated with the expression levels of HK2 and HK1. The correlations between the expression of electron transport chain (ETC) proteins and the oxygen consumption rates or extracellular acidification rates were weak. ER stress markers were strongly expressed in all the analyzed tumors. ER stress was further potentiated by tunicamycin but not by the recently proposed ER stress inducers based on copper(II)-phenanthroline complexes. ER stress modulation increased autophagy in tumor cell isolates but not in nontransformed ovarian fibroblasts. CONCLUSIONS: Analysis of the metabolism of primary HGSOC cells rejects the previously proposed hypothesis that there are distinct groups of HGSOC cells with high and low OXPHOS metabolism that respond differently to glutamine or glucose withdrawal and are characterized by ETC protein levels.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24017809
003      
CZ-PrNML
005      
20241016081829.0
007      
ta
008      
241008s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s40170-024-00355-1 $2 doi
035    __
$a (PubMed)39285269
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Šimčíková, Daniela $u Third Faculty of Medicine, Charles University, Ruská 87, Prague, CZ-100 00, Czech Republic
245    10
$a Metabolism of primary high-grade serous ovarian carcinoma (HGSOC) cells under limited glutamine or glucose availability / $c D. Šimčíková, D. Gardáš, T. Pelikán, L. Moráň, M. Hruda, K. Hložková, T. Pivetta, M. Hendrych, J. Starková, L. Rob, P. Vaňhara, P. Heneberg
520    9_
$a BACKGROUND: High-grade serous ovarian carcinoma (HGSOC) is the most common and aggressive subtype of epithelial ovarian carcinoma. It is primarily diagnosed at stage III or IV when the 5-year survival rate ranges between 20% and 40%. Here, we aimed to validate the hypothesis, based on HGSOC cell lines, that proposed the existence of two distinct groups of HGSOC cells with high and low oxidative phosphorylation (OXPHOS) metabolism, respectively, which are associated with their responses to glucose and glutamine withdrawal. METHODS: We isolated and cultivated primary cancer cell cultures from HGSOC and nontransformed ovarian fibroblasts from the surrounding ovarium of 45 HGSOC patients. We tested the metabolic flexibility of the primary cells, particularly in response to glucose and glutamine depletion, analyzed and modulated endoplasmic reticulum stress, and searched for indices of the existence of previously reported groups of HGSOC cells with high and low OXPHOS metabolism. RESULTS: The primary HGSOC cells did not form two groups with high and low OXPHOS that responded differently to glucose and glutamine availabilities in the cell culture medium. Instead, they exhibited a continuum of OXPHOS phenotypes. In most tumor cell isolates, the responses to glucose or glutamine withdrawal were mild and surprisingly correlated with those of nontransformed ovarian fibroblasts from the same patients. The growth of tumor-derived cells in the absence of glucose was positively correlated with the lipid trafficking regulator FABP4 and was negatively correlated with the expression levels of HK2 and HK1. The correlations between the expression of electron transport chain (ETC) proteins and the oxygen consumption rates or extracellular acidification rates were weak. ER stress markers were strongly expressed in all the analyzed tumors. ER stress was further potentiated by tunicamycin but not by the recently proposed ER stress inducers based on copper(II)-phenanthroline complexes. ER stress modulation increased autophagy in tumor cell isolates but not in nontransformed ovarian fibroblasts. CONCLUSIONS: Analysis of the metabolism of primary HGSOC cells rejects the previously proposed hypothesis that there are distinct groups of HGSOC cells with high and low OXPHOS metabolism that respond differently to glutamine or glucose withdrawal and are characterized by ETC protein levels.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gardáš, Dominik $u Third Faculty of Medicine, Charles University, Ruská 87, Prague, CZ-100 00, Czech Republic
700    1_
$a Pelikán, Tomáš $u Third Faculty of Medicine, Charles University, Ruská 87, Prague, CZ-100 00, Czech Republic
700    1_
$a Moráň, Lukáš $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Research Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Hruda, Martin $u Third Faculty of Medicine, Charles University, Ruská 87, Prague, CZ-100 00, Czech Republic $u University Hospital Kralovské Vinohrady, Prague, Czech Republic
700    1_
$a Hložková, Kateřina $u Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, CLIP - Childhood Leukaemia Investigation Prague, Charles University, Prague, Czech Republic
700    1_
$a Pivetta, Tiziana $u Department of Chemical and Geological Sciences, University of Cagliari, Monserrato, CA, Italy
700    1_
$a Hendrych, Michal $u First Department of Pathology, St. Anne's University Hospital, Brno, Czech Republic $u First Department of Pathology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Starková, Júlia $u Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, CLIP - Childhood Leukaemia Investigation Prague, Charles University, Prague, Czech Republic $u Motol University Hospital, Prague, Czech Republic
700    1_
$a Rob, Lukáš $u Third Faculty of Medicine, Charles University, Ruská 87, Prague, CZ-100 00, Czech Republic $u University Hospital Kralovské Vinohrady, Prague, Czech Republic
700    1_
$a Vaňhara, Petr $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic
700    1_
$a Heneberg, Petr $u Third Faculty of Medicine, Charles University, Ruská 87, Prague, CZ-100 00, Czech Republic. petr.heneberg@lf3.cuni.cz
773    0_
$w MED00208612 $t Cancer & metabolism $x 2049-3002 $g Roč. 12, č. 1 (2024), s. 27
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39285269 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241008 $b ABA008
991    __
$a 20241016081824 $b ABA008
999    __
$a ok $b bmc $g 2196378 $s 1229760
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 12 $c 1 $d 27 $e 20240916 $i 2049-3002 $m Cancer & metabolism $n Cancer Metab $x MED00208612
GRA    __
$a 324421 $p Univerzita Karlova v Praze
GRA    __
$a 324421 $p Univerzita Karlova v Praze
GRA    __
$a 324421 $p Univerzita Karlova v Praze
GRA    __
$a NU21-03-00539 $p Agentura Pro Zdravotnický Výzkum České Republiky
LZP    __
$a Pubmed-20241008

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...